Learning Objectives 1. Gain awareness of potential obstacles and considerations when introducing DaTscan at an imaging facility. 2. Identify planning tools for successful implementation of the DaTscan ...

DaTscan is first radiopharmaceutical diagnostic tracer approved by U.S. FDA for use in patients with suspected Dementia with Lewy Bodies (DLB) Builds on DaTscan market leadership globally with over ...

SimonMed is proud to announce we will offer GE HealthCare’s radiopharmaceutical diagnostic tracer, DaTscan™, with DaTQUANT™ nationally starting immediately in all of our markets. SCOTTSDALE, Ariz., ...

GE Healthcare’s DaTscan has been approved by the U.S. Food and Drug Administration (FDA) for use in patients with suspected Dementia with Lewy Bodies (DLB). DaTscan is first radiopharmaceutical ...